Education

Pharma's role in cost control

Pharma's role in cost control

It may be time to adopt a model in which we help deliver healthcare

ACCME tables logo ban again

ACCME tables logo ban again

After a wave of feedback, the accreditor has deferred a ban on use of corporate logos in disclosures of commercial support.

Study finds heart health knowledge lacking

The Cleveland Clinic finds that 75% of Americans don't worry about dying of heart disease, even though it's the country's leading killer.

Medicate responsibly, urges maker of Tylenol

Medicate responsibly, urges maker of Tylenol

J&J's campaign picks up where the FDA left off when it alerted physicians to concerns about prescribing acetaminophen-containing drugs but deferred action relative to OTC products.

ACCME closer to revising criteria

The accreditor wants comments on its new accreditation plan, but a new commendation proposal is yet to come.

Proposed guidelines kick industry off campus

Proposed guidelines kick industry off campus

Pew Charitable Trust's proposed conflict of interest guidelines could mean even less face time for sales reps and less industry money for CME programs.

Lippincott deepens CE, research connection

Lippincott deepens CE, research connection

The publisher says the latest release enriches the CE experience through direct links to Nursing Advisor content.

OPDP expands "Bad Ad" with CME

OPDP expands "Bad Ad" with CME

The agency made good on a pledge to expand Bad Ad with a web-based CME course and case studies representing common problems.

Rebound seen in HCP meeting turnout: report

Rebound seen in HCP meeting turnout: report

Attendance by physicians crept up in 2012, said the trade group HCEA, but overall turnout was flat, likely because exhibitors brought less personnel along to meetings.

CME compliance trends up among some outfits

Some providers of CME are getting better at complying with accreditation criteria, data show, yet many are still struggling to meet a stricter set of requirements.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.